Skip to main content
Log in

Cardiac resynchronization therapy evaluated by myocardial scintigraphy with 99mTc-MIBI: changes in left ventricular uptake, dyssynchrony, and function

  • Original article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

99mTc-MIBI gated myocardial scintigraphy (GMS) evaluates myocyte integrity and perfusion, left ventricular (LV) dyssynchrony and function. Cardiac resynchronization therapy (CRT) may improve the clinical symptoms of heart failure (HF), but its benefits for LV function are less pronounced. We assessed whether changes in myocardial 99mTc-MIBI uptake after CRT are related to improvement in clinical symptoms, LV synchrony and performance, and whether GMS adds information for patient selection for CRT.

Methods

A group of 30 patients with severe HF were prospectively studied before and 3 months after CRT. Variables analysed were HF functional class, QRS duration, LV ejection fraction (LVEF) by echocardiography, myocardial 99mTc-MIBI uptake, LV end-diastolic volume (EDV) and end-systolic volume (ESV), phase analysis LV dyssynchrony indices, and regional motion by GMS. After CRT, patients were divided into two groups according to improvement in LVEF: group 1 (12 patients) with increase in LVEF of 5 or more points, and group 2 (18 patients) without a significant increase.

Results

After CRT, both groups showed a significant improvement in HF functional class, reduced QRS width and increased septal wall 99mTc-MIBI uptake. Only group 1 showed favourable changes in EDV, ESV, LV dyssynchrony indices, and regional motion. Before CRT, EDV, and ESV were lower in group 1 than in group 2. Anterior and inferior wall 99mTc-MIBI uptakes were higher in group 1 than in group 2 (p<0.05). EDV was the only independent predictor of an increase in LVEF (p=0.01). The optimal EDV cut-off point was 315 ml (sensitivity 89%, specificity 94%).

Conclusion

The evaluation of EDV by GMS added information on patient selection for CRT. After CRT, LVEF increase occurred in hearts less dilated and with more normal 99mTc-MIBI uptake.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002;143(3):398–405.

    Article  PubMed  Google Scholar 

  2. Prinzen FW, Augustijn CH, Arts T, Allessie MA, Reneman RS. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol 1990;259(2 Pt 2):H300–8.

    PubMed  CAS  Google Scholar 

  3. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(6 Suppl):VI17–23.

    PubMed  CAS  Google Scholar 

  4. Nicod P, Gilpin E, Dittrich H, Chappuis F, Ahnve S, Engler R, et al. Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction. Am J Cardiol 1988;61(15):1165–71.

    Article  PubMed  CAS  Google Scholar 

  5. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26(11):1115–40.

    Article  PubMed  Google Scholar 

  6. Hunt SA; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46(6):e1–82.

    Article  PubMed  Google Scholar 

  7. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. MIRACLE Study Group. Multicenter Insync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–53.

    Article  PubMed  Google Scholar 

  8. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, et al. Cardiac resynchronization and death from progressive heart failure – a meta-analysis of randomized controlled trials. JAMA 2003;289(6):730–40.

    Article  PubMed  Google Scholar 

  9. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure (CARE-HF study). N Engl J Med 2005;352:1539–49.

    Article  PubMed  CAS  Google Scholar 

  10. Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002;105(4):438–45.

    Article  PubMed  Google Scholar 

  11. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, et al. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107(15):1985–90.

    Article  PubMed  Google Scholar 

  12. McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E, et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004;141:381–90.

    PubMed  Google Scholar 

  13. Nishijima Y, Sridhar A, Viatchenko-Karpinski S, Shaw C, Bonagura JD, Abraham WT. Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathy. Life Sci 2007;81(14):1152–9.

    Article  PubMed  CAS  Google Scholar 

  14. Chakir K, Daya SK, Tunin RS, Helm RH, Byrne MJ, Dimaano VL. Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation 2008;117(11):1369–77.

    Article  PubMed  Google Scholar 

  15. Nishioka SAD, Martinelli Filho M, Brandão SCS, Giorgi MC, Vieira MLC, Costa R, et al. Cardiac sympathetic activity pre- and post-resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy. J Nucl Cardiol 2007;14(6):852–9.

    Article  PubMed  Google Scholar 

  16. Brandão SC, Giorgi MC, de Miche RT, Nishioka SD, Lopes RW, Izaki M, et al. Ventricular synchrony in patients with dilated cardiomyopathy and normal individuals: assessment by radionuclide ventriculography. Arq Bras Cardiol 2007;88:596–601.

    Article  PubMed  Google Scholar 

  17. Brandao S, Cagnac R, Roncalli J, Lotterie JA, Elbaz M, Richez F, et al. Identification of viable myocardium in ischemic heart disease with severe left ventricular contractile dysfunction: comparison of myocardial scintigraphy with 99mTc-sestamibi and with 201-thallium. Arch Mal Coeur Vaiss 2005;98(6):620–7.

    PubMed  CAS  Google Scholar 

  18. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990;31(10):1646–53.

    PubMed  CAS  Google Scholar 

  19. Van Train KF, Areeda J, Garcia EV, Cooke CD, Maddahi J, Kiat H, et al. Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993;34(9):1494–502.

    PubMed  Google Scholar 

  20. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36(11):2138–47.

    PubMed  CAS  Google Scholar 

  21. Sharir T, Berman DS, Waechter PB, Areeda J, Kavanagh PB, Gerlach J, et al. Quantitative analysis of regional motion and thickening by gated myocardial perfusion SPECT: normal heterogeneity and criteria for abnormality. J Nucl Med 2001;42(11):1630–8.

    PubMed  CAS  Google Scholar 

  22. Chen J, Garcia EV, Folks RD, Cooke CD, Faber TL, Tauxe EL, et al. Onset of left ventricular contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol 2005;6:687–95.

    Article  Google Scholar 

  23. Henneman MM, Chen J, Ypenburg C, Dibbets P, Bleeker GB, Boersma E, et al. Phase analysis of gated myocardial perfusion single-photon emission computed tomography compared with tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J Am Coll Cardiol 2007;49:1708–14.

    Article  PubMed  Google Scholar 

  24. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on quantification of Two-Dimension Echocardiograms. J Am Soc Echocardiogr 1989;2:358–67.

    PubMed  CAS  Google Scholar 

  25. Lee TH, Hamilton MA, Stevenson LW, Moriguchi JD, Fonarow GC, Child JS, et al. Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 1993;72(9):672–6.

    Article  PubMed  CAS  Google Scholar 

  26. Sciagrà R, Giaccardi M, Porciani MC, Colella A, Michelucci A, Pieragnoli P, et al. Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med 2004;45(2):164–8.

    PubMed  Google Scholar 

  27. Butter C, Auricchio A, Stellbrink C, Fleck E, Ding J, Yu Y, et al. Pacing Therapy for Chronic Heart Failure II Study Group. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001;104(25):3026–9.

    Article  PubMed  CAS  Google Scholar 

  28. Lindner O, Vogt J, Kammeier A, Wielepp P, Holzinger J, Baller D, et al. Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy. Eur Heart J 2005;26(1):70–6.

    Article  PubMed  Google Scholar 

  29. Ukkonen H, Beanlands RS, Burwash IG, de Kemp RA, Nahmias C, Fallen E, et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 2003;107(1):28–31.

    Article  PubMed  CAS  Google Scholar 

  30. Nowak B, Stellbrink C, Sinha AM, Kaiser HJ, Reinartz P, Koos R, et al. Effects of cardiac resynchronization therapy on myocardial blood flow measured by oxygen-15 water positron emission tomography in idiopathic-dilated cardiomyopathy and left bundle branch block. Am J Cardiol 2004;93(4):496–9.

    Article  PubMed  Google Scholar 

  31. Matsuo S, Nakae I, Tsutamoto T, Okamoto N, Horie M. A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies. J Nucl Cardiol 2007;14(2):215–20.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was partially supported by São Paulo State Research Foundation (FAPESP, project number no. 04/12160-3), and it was part of the PhD thesis of Dr. Brandão.

Conflicts of interest

Dr. Ernest V. Garcia receives royalties from the sale of the Emory Cardiac Toolbox. The other authors have no financial conflicts.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simone C. S. Brandão.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brandão, S.C.S., Nishioka, S.A.D., Giorgi, M.C.P. et al. Cardiac resynchronization therapy evaluated by myocardial scintigraphy with 99mTc-MIBI: changes in left ventricular uptake, dyssynchrony, and function. Eur J Nucl Med Mol Imaging 36, 986–996 (2009). https://doi.org/10.1007/s00259-008-1029-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-008-1029-1

Keywords

Navigation